Mitesco Pivots to Tech, Registers 105M Shares Post-$26.5M Debt Restructure

TL;DR

**MITI is a highly speculative bet on a pivot to tech after a massive debt restructuring, expect significant dilution and volatility.**

AI Summary

Mitesco, Inc. (MITI) is filing an S-1/A to register 105,002,758 shares of common stock for resale by selling stockholders, primarily stemming from a significant debt restructuring. The company, which previously operated 'The Good Clinic' medical clinics and ceased operations in late FY2022 due to unprofitability, has pivoted to a holding company model focused on data center services and cloud computing. In FY2024 and FY2025, Mitesco converted approximately $26.5 million of financial obligations, including $21.5 million in senior securities and $2.5 million in notes and accounts payable, into 2,628,179 shares of restricted Common Stock and 562,998 Series A Preferred Stock. Additionally, $580,132 of 2024 Bridge Notes were extinguished by converting them into 23,206 Series A Preferred shares. The company launched two new wholly-owned business units in June 2024: Centcore, providing data center and cloud computing services, and Vero Technology Ventures (VTV), focusing on investments and acquisitions in cloud computing and developing AI-based applications like 'Robo Agent' for real estate, expected Q4 FY2025. The common stock currently trades on the OTC-QB Venture Market at $0.14 as of December 4, 2025.

Why It Matters

This S-1/A filing signals a critical juncture for Mitesco, as it attempts to shed its past healthcare clinic failures and re-establish itself in the competitive cloud computing and data center market. For investors, the massive share registration for resale, totaling 105,002,758 shares, introduces significant potential dilution and selling pressure on the OTC-QB Venture Market, where the stock trades at $0.14. Employees and customers of the new Centcore and VTV units face uncertainty given the company's history of strategic shifts and the highly speculative nature of its new ventures. The broader market will watch to see if Mitesco can successfully transition into a viable technology player amidst established giants and numerous startups in the cloud and AI space.

Risk Assessment

Risk Level: high — The company explicitly states, 'Investing in the Common Stock is highly speculative and involves a high degree of risk.' Mitesco has an 'evolving business model' and needs to 'raise additional capital to fund our operations.' The registration of 105,002,758 shares for resale by selling stockholders, including those who converted $26.5 million in debt, indicates substantial potential dilution and downward pressure on the stock price, which was $0.14 on December 4, 2025.

Analyst Insight

Investors should exercise extreme caution and thoroughly review the 'Risk Factors' section. Given the significant potential for dilution from the 105,002,758 shares being registered for resale and the company's history of failed ventures, it would be prudent to avoid MITI until there is clear evidence of sustained profitability and a stable business model in its new technology focus.

Key Numbers

• 105,002,758 — Shares of Common Stock (Total shares registered for resale by Selling Stockholders, indicating potential dilution.)
• $26.5 million — Converted Obligations (Amount of financial obligations converted into common and Series A preferred stock during FY2024 restructuring.)
• 2,628,179 — Restricted Common Stock Shares (Shares issued in connection with restructuring $12.5 million of financial obligations.)
• 97,779,013 — Common Stock Shares Issuable (Shares issuable upon mandatory redemption of Series A Amortizing Convertible Preferred Stock.)
• $0.14 — Common Stock Closing Price (Last reported closing price on OTC-QB Venture Market as of December 4, 2025.)
• 562,998 — Series A Preferred Stock Shares (Shares issued to institutional investors in exchange for Series D and F Preferred Shares (before FY2025 redemptions).)
• $580,132 — 2024 Bridge Notes Extinguished (Amount of short-term debt converted into Series A Preferred shares, extinguishing all 2024 bridge notes.)
• Q4 FY2025 — Robo Agent Availability (Expected initial user availability for the new AI-based application.)

Key Players & Entities

• Mitesco, Inc. (company) — Registrant and issuer of common stock
• Mack Leath (person) — Chief Executive Officer of Mitesco, Inc.
• Centcore, LLC (company) — Wholly-owned business unit providing data center services
• Vero Technology Ventures, LLC (company) — Wholly-owned business unit seeking investment and acquisition opportunities in cloud computing and AI
• The Good Clinic (company) — Former operating subsidiary focused on medical clinics, now discontinued operations
• Securities and Exchange Commission (regulator) — Regulatory body for the S-1/A filing
• $12.5 million (dollar_amount) — Value of financial obligations restructured into common stock
• $14 million (dollar_amount) — Value of Series D and Series F Preferred Shares exchanged for Series A Preferred Stock
• $26.5 million (dollar_amount) — Total obligations converted in FY2024 debt restructuring
• $0.14 (dollar_amount) — Last reported closing price of Common Stock on December 4, 2025

FAQ

Risk Factors

• Pivot to New Business Model [high — operational]: The company has ceased operations of its previous 'The Good Clinic' medical clinics due to unprofitability and is pivoting to a holding company model focused on data center services and cloud computing. This transition involves significant execution risk, as the success of new ventures like Centcore and Vero Technology Ventures (VTV) is unproven.
• Significant Debt Conversion and Dilution [high — financial]: Approximately $26.5 million in financial obligations, including senior securities and notes, were converted into over 3.19 million shares of common and Series A preferred stock. The current S-1/A registers 105,002,758 shares for resale, indicating substantial potential dilution for existing shareholders.
• Dependence on New Ventures [high — market]: The company's future financial performance is heavily reliant on the success of its newly launched business units, Centcore and VTV. The development and market adoption of services like data center solutions and AI applications such as 'Robo Agent' (expected Q4 FY2025) are critical and subject to market competition and technological advancements.
• Limited Operating History in New Segments [medium — financial]: Mitesco has a limited operating history in the data center and cloud computing sectors. The company's ability to generate revenue and achieve profitability in these new areas is uncertain, especially given the competitive landscape and the need for significant investment.
• OTC-QB Market Volatility [medium — market]: The company's common stock currently trades on the OTC-QB Venture Market at $0.14 as of December 4, 2025. This market is generally less liquid and more volatile than major exchanges, potentially impacting stock price stability and investor confidence.

Industry Context

Mitesco is pivoting into the data center services and cloud computing industry, a sector characterized by rapid technological advancement, high capital expenditure requirements, and intense competition from established players and emerging startups. The AI application development segment, particularly for real estate, is a rapidly growing niche within this broader tech landscape, driven by demand for automation and data-driven insights.

Regulatory Implications

As a company whose stock is traded on the OTC-QB Venture Market and filing with the SEC, Mitesco is subject to ongoing disclosure requirements. The conversion of debt into equity and the subsequent resale of these shares necessitate compliance with securities regulations to protect investors from potential fraud and ensure market integrity.

What Investors Should Do

1. Monitor new venture performance closely.
2. Assess dilution impact.
3. Evaluate management's execution capabilities.
4. Consider market volatility.

Key Dates

• 2024: Debt Restructuring and Conversion — Approximately $26.5 million in financial obligations were converted into equity, significantly altering the company's capital structure and leading to the current registration of shares for resale.
• June 2024: Launch of Centcore and Vero Technology Ventures (VTV) — Marks the strategic pivot to data center services, cloud computing, and AI applications, representing the company's new core business focus.
• Q4 FY2025: Expected Availability of 'Robo Agent' — Indicates a near-term milestone for the company's AI development efforts, which is a key component of its VTV venture.
• 2025-12-04: Common Stock Closing Price — The stock was trading at $0.14 on the OTC-QB Venture Market, reflecting its current market valuation and potential for significant price volatility.

Glossary

S-1/A

An amendment to a registration statement filed with the SEC, typically used to update or correct information previously filed on Form S-1. (This filing is an amendment to Mitesco's registration statement, indicating ongoing updates to its securities offering and financial disclosures.)

Selling Stockholders

Entities or individuals who own securities and are offering them for sale to the public, as opposed to the issuing company itself. (The primary purpose of this S-1/A is to register shares for resale by these stockholders, stemming from debt conversions.)

Senior Securities

A class of debt or equity securities that have a higher claim on assets and earnings than other securities in the event of liquidation or bankruptcy. (A significant portion of Mitesco's debt ($21.5 million) consisted of senior securities that were converted into equity.)

Series A Amortizing Convertible Preferred Stock

A type of preferred stock that can be converted into common stock and is designed to be redeemed over time (amortizing). (A large number of common stock shares (97,779,013) are issuable upon the mandatory redemption of this preferred stock, highlighting a significant future dilution event.)

OTC-QB Venture Market

A quotation service for over-the-counter (OTC) traded stocks that meet certain financial and disclosure standards, generally considered a market for smaller, emerging companies. (Mitesco's common stock is currently traded on this market, which is associated with higher volatility and lower liquidity compared to major exchanges.)

Holding Company

A company whose primary business is holding a controlling interest in the securities of other companies. (Mitesco has pivoted to this model, focusing on its new data center and cloud computing ventures rather than direct operational management of clinics.)

Year-Over-Year Comparison

This S-1/A filing represents a significant strategic shift from Mitesco's previous operations as 'The Good Clinic,' which ceased due to unprofitability. Key metrics such as revenue, net income, and margins from the prior business are no longer relevant to the company's future prospects. The current filing focuses on the potential dilution from debt conversions and the nascent stage of new data center and cloud computing ventures, introducing new risks related to market entry and execution in these sectors.

Key Financial Figures

• $0.01 — 2,758 shares of common stock, par value $0.01 per share (the "Common Stock") of Mites
• $12.5 million — with the restructuring of approximately $12.5 million worth of financial obligations includin
• $14 million — tutional investors in exchange for over $14 million worth of its Series D and Series F Pref
• $0.14 — d closing price of our Common Stock was $0.14. There is currently no trading history
• $10,000 — set on a consulting basis at a rate of $10,000 per month. We have also recruited three
• $30 million — of June 30, 2024, the Company had over $30 million in senior securities, notes and account
• $4.00 — common stock using a price per share of $4.00. As of the date of this filing it has
• $21.5 million — obligations, representing approximately $21.5 million of its senior securities, and approxima
• $2.5 million — ts senior securities, and approximately $2.5 million of notes and accounts payable, into 2,6
• $4 — ected to receive common stock using the $4 per share valuation. 2 Table of Cont
• $580,132 — ents pursuant to which it has converted $580,132, including $32,132 of principal and int
• $32,132 — ch it has converted $580,132, including $32,132 of principal and interest, of its 2024
• $100,000 — stock were issued for consideration of $100,000; The Q2 redemptions of Series A Prefe
• $25,000 — were issued for total consideration of $25,000. As part of the restructuring, the Co
• $1 m — L.P. with a potential total funding of $1 million, with an initial funding of $250,

Filing Documents

• mitis1a3082925.htm (S-1/A) — 2941KB
• mitiex5-1.htm (EX-5.1) — 14KB
• mitiex23-1.htm (EX-23.1) — 3KB
• mitiex-fee.htm (EX-FILING FEES) — 14KB
• image_001.jpg (GRAPHIC) — 3KB
• image_002.jpg (GRAPHIC) — 50KB
• image_003.jpg (GRAPHIC) — 9KB
• ex5-1_001.jpg (GRAPHIC) — 11KB
• ex5-1_002.jpg (GRAPHIC) — 17KB
• ex23-1_001.jpg (GRAPHIC) — 16KB
• ex23-1_002.jpg (GRAPHIC) — 6KB
• 0001185185-25-001944.txt ( ) — 13720KB
• miti-20250930.xsd (EX-101.SCH) — 97KB
• miti-20250930_cal.xml (EX-101.CAL) — 73KB
• miti-20250930_def.xml (EX-101.DEF) — 498KB
• miti-20250930_lab.xml (EX-101.LAB) — 772KB
• miti-20250930_pre.xml (EX-101.PRE) — 532KB
• mitis1a3082925_htm.xml (XML) — 1800KB
• mitiex-fee_htm.xml (XML) — 5KB

RISK FACTORS

RISK FACTORS 8 MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY 18 DIVIDEND POLICY 18

USE OF PROCEEDS

USE OF PROCEEDS 18

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 23 DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE 30

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 34 DIRECTOR COMPENSATION 35

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 36 SELLING STOCKHOLDERS 37 DESCRIPTION OF OUR CAPITAL STOCK 45 PLAN OF DISTRIBUTION 50 EXPERTS 51 LEGAL MATTERS 51 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT 51 WHERE YOU CAN FIND MORE INFORMATION 52 INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS F-1 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a Registration Statement on Form S-1 that we filed with the SEC. The Selling Stockholders may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by the Selling Stockholder of the securities described in this prospectus. You should rely only on the information contained in this prospectus, any supplement to this prospectus or in any free writing prospectus, filed with the SEC. Neither we nor the Selling Stockholders have authorized anyone to provide you with additional information or information different from that contained in this prospectus, or any applicable prospectus supplement or any free writing prospectuses prepared by us or on our behalf and filed with the SEC. We take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. The Selling Stockholders are offering to sell our securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to these offerings. The prospectus supplement or post

View Full Filing

View this S-1/A filing on SEC EDGAR